Cellebrite DI (CLBT) Payables (2020 - 2026)

Cellebrite DI has reported Payables for 7 years, with the latest figure at $18.1 million in Q2 2026.

• On a quarterly basis, Payables rose 71.09% year-over-year to $18.1 million in Q2 2026; TTM through Jun 2026 was $18.1 million, a 71.09% increase from a year earlier, with the FY2025 full-year figure at $17.0 million, up 53.82% from the prior year.
• Payables was $18.1 million for Q2 2026 at Cellebrite DI, up from $10.9 million in the prior quarter.
• The five-year high for Payables was $62.4 million in Q4 2023, with the low at $3.8 million in Q2 2022.
• Average Payables over 5 years is $11.8 million, with a median of $8.6 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Payables surged 1252.97% in 2023, then plunged 82.25% in 2024.
• Over 5 years, Payables stood at $4.6 million in 2022, then soared by 1252.97% to $62.4 million in 2023, then slumped by 82.25% to $11.1 million in 2024, then soared by 53.82% to $17.0 million in 2025, then advanced by 6.3% to $18.1 million in 2026.
• The last three Payables figures came in at $18.1 million (Q2 2026), $10.9 million (Q1 2026), and $17.0 million (Q4 2025), per Business Quant data.